Services on Demand
Journal
Article
Indicators
Cited by SciELO
Access statistics
Related links
Cited by Google
Similars in SciELO
Similars in Google
Share
Revista Colombiana de Reumatología
Print version ISSN 0121-8123
Abstract
ERASO G, Ruth et al. Anti tumor necrosis factor therapy in Juvenile idiopathic arthritis. Rev.Colomb.Reumatol. [online]. 2006, vol.13, n.2, pp.154-168. ISSN 0121-8123.
From benefits observed in adults suffering rheumatoid arthritis treated with antagonists of tumoral necrosis factor, there was a growing interest about its use in children. However several conditions pertaining to pediatric rheumatology determine that available evidence be poor or of low quality. As a result of a critical review of the literature and after a consensus meeting a Practical Clinical Guide is presented: its purpose consist in offering recommendations for the rational use of these medications.
Keywords : pediatric rheumatology; children; juvenile idiopathic arthritis; juvenile rheumatoid arthritis; tumor necrosis factor antagonists; etanercept; infliximab; adalimumab; efficacy; indications; doses; security; adverse effects.